Nu Skin Enterprises, Inc. (NUS) stock
NUSNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/3069% below fair value
$3.78−0.15 (-3.82%)
Close on Nov 17, 2026Market cap $184.00MP/E –Yield –
Nu Skin Enterprises revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Nu Skin Enterprises's revenue for the twelve months ending Sep 30, 2026 was $1.32B, down 15.3% year over year. For fiscal 2025 it was $1.49B, down 14.3% from the year before. Over ten years it grew -4.1% a year on average. The highest annual figure on record is $3.18B in fiscal 2013.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.49B | -14.3% |
| FY2024 | Dec 31, 2024 | $1.73B | -12.0% |
| FY2023 | Dec 31, 2023 | $1.97B | -11.5% |
| FY2022 | Dec 31, 2022 | $2.23B | -17.4% |
| FY2021 | Dec 31, 2021 | $2.70B | +4.4% |
| FY2020 | Dec 31, 2020 | $2.58B | +6.7% |
| FY2019 | Dec 31, 2019 | $2.42B | -9.7% |
| FY2018 | Dec 31, 2018 | $2.68B | +17.5% |
| FY2017 | Dec 31, 2017 | $2.28B | +3.2% |
| FY2016 | Dec 31, 2016 | $2.21B | -1.7% |
| FY2015 | Dec 31, 2015 | $2.25B | -12.5% |
| FY2014 | Dec 31, 2014 | $2.57B | -19.1% |
| FY2013 | Dec 31, 2013 | $3.18B | +49.0% |
| FY2012 | Dec 31, 2012 | $2.13B | +24.0% |
| FY2011 | Dec 31, 2011 | $1.72B | +11.9% |
| FY2010 | Dec 31, 2010 | $1.54B | +15.5% |
| FY2009 | Dec 31, 2009 | $1.33B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $311.01M | -14.6% |
| Q2 FY2026 | Jun 30, 2026 | $320.11M | -17.1% |
| Q1 FY2026 | Mar 31, 2026 | $320.61M | -12.0% |
| Q4 FY2025 | Dec 31, 2025 | $370.32M | -16.9% |
| Q3 FY2025 | Sep 30, 2025 | $364.21M | -15.3% |
| Q2 FY2025 | Jun 30, 2025 | $386.14M | -12.1% |
| Q1 FY2025 | Mar 31, 2025 | $364.49M | -12.7% |
| Q4 FY2024 | Dec 31, 2024 | $445.55M | -8.8% |
| Q3 FY2024 | Sep 30, 2024 | $430.15M | -13.8% |
| Q2 FY2024 | Jun 30, 2024 | $439.08M | -12.2% |
| Q1 FY2024 | Mar 31, 2024 | $417.31M | -13.3% |
| Q4 FY2023 | Dec 31, 2023 | $488.64M | -6.5% |
| Q3 FY2023 | Sep 30, 2023 | $498.77M | -7.3% |
| Q2 FY2023 | Jun 30, 2023 | $500.26M | -10.8% |
| Q1 FY2023 | Mar 31, 2023 | $481.46M | -20.4% |
| Q4 FY2022 | Dec 31, 2022 | $522.34M | -22.4% |
| Q3 FY2022 | Sep 30, 2022 | $537.81M | -16.1% |
| Q2 FY2022 | Jun 30, 2022 | $560.62M | -20.4% |
| Q1 FY2022 | Mar 31, 2022 | $604.90M | -10.7% |
| Q4 FY2021 | Dec 31, 2021 | $673.44M | -10.0% |
| Q3 FY2021 | Sep 30, 2021 | $641.15M | -8.8% |
| Q2 FY2021 | Jun 30, 2021 | $704.06M | +15.0% |
| Q1 FY2021 | Mar 31, 2021 | $677.03M | +30.7% |
| Q4 FY2020 | Dec 31, 2020 | $748.19M | +28.3% |
| Q3 FY2020 | Sep 30, 2020 | $703.35M | +19.2% |
| Q2 FY2020 | Jun 30, 2020 | $612.37M | -1.8% |
| Q1 FY2020 | Mar 31, 2020 | $518.03M | -16.9% |
| Q4 FY2019 | Dec 31, 2019 | $583.36M | -14.6% |
| Q3 FY2019 | Sep 30, 2019 | $589.93M | -12.6% |
| Q2 FY2019 | Jun 30, 2019 | $623.50M | -11.5% |
| Q1 FY2019 | Mar 31, 2019 | $623.62M | +1.2% |
| Q4 FY2018 | Dec 31, 2018 | $683.29M | +2.6% |
| Q3 FY2018 | Sep 30, 2018 | $675.31M | +19.8% |
| Q2 FY2018 | Jun 30, 2018 | $704.19M | +28.0% |
| Q1 FY2018 | Mar 31, 2018 | $616.22M | +23.5% |
| Q4 FY2017 | Dec 31, 2017 | $666.20M | +25.4% |
| Q3 FY2017 | Sep 30, 2017 | $563.70M | – |
| Q2 FY2017 | Jun 30, 2017 | $550.10M | – |
| Q1 FY2017 | Mar 31, 2017 | $499.10M | – |
| Q4 FY2016 | Dec 31, 2016 | $531.33M | – |
See a number that looks wrong?